Peter J. Conroy

661 total citations
28 papers, 491 citations indexed

About

Peter J. Conroy is a scholar working on Otorhinolaryngology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter J. Conroy has authored 28 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Otorhinolaryngology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter J. Conroy's work include Ear Surgery and Otitis Media (7 papers), Respiratory and Cough-Related Research (4 papers) and Virus-based gene therapy research (3 papers). Peter J. Conroy is often cited by papers focused on Ear Surgery and Otitis Media (7 papers), Respiratory and Cough-Related Research (4 papers) and Virus-based gene therapy research (3 papers). Peter J. Conroy collaborates with scholars based in United States, United Kingdom and China. Peter J. Conroy's co-authors include Robert M. Sutherland, Peter S. Roland, G. Michael Wall, Susan Potts, R. von Burg, R. L. Willson, A. Searle, Josh Foster, David W. Stroman and Jack B. Anon and has published in prestigious journals such as PEDIATRICS, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Peter J. Conroy

28 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Conroy United States 14 184 135 102 86 53 28 491
Rui Zheng China 17 135 0.7× 81 0.6× 186 1.8× 27 0.3× 35 0.7× 60 850
Ayame Enomoto Japan 11 66 0.4× 40 0.3× 315 3.1× 87 1.0× 31 0.6× 18 553
Qisheng Zheng China 7 18 0.1× 80 0.6× 271 2.7× 21 0.2× 88 1.7× 12 494
Ruxian Lin United States 16 11 0.1× 97 0.7× 407 4.0× 118 1.4× 91 1.7× 40 722
Guangzhao Huang China 14 13 0.1× 66 0.5× 282 2.8× 176 2.0× 68 1.3× 33 446
Tianlin Xiao China 10 19 0.1× 18 0.1× 214 2.1× 58 0.7× 36 0.7× 30 501
Jianguo Cui China 17 8 0.0× 87 0.6× 181 1.8× 89 1.0× 69 1.3× 35 632
Birgit Jung Germany 15 8 0.0× 237 1.8× 189 1.9× 68 0.8× 93 1.8× 23 697
Nurcan Aras Ateş Türkiye 16 12 0.1× 35 0.3× 509 5.0× 58 0.7× 43 0.8× 22 744

Countries citing papers authored by Peter J. Conroy

Since Specialization
Citations

This map shows the geographic impact of Peter J. Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Conroy more than expected).

Fields of papers citing papers by Peter J. Conroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Conroy. The network helps show where Peter J. Conroy may publish in the future.

Co-authorship network of co-authors of Peter J. Conroy

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Conroy. A scholar is included among the top collaborators of Peter J. Conroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Conroy. Peter J. Conroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roland, Peter S., et al.. (2008). A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa. American Journal of Otolaryngology. 29(4). 255–261. 19 indexed citations
2.
Dohar, Joseph E., Michael Wall, Peter S. Roland, et al.. (2005). Topical Ciprofloxacin/Dexamethasone Found Superior to Oral Amoxicillin/Clavulanic Acid in Acute Otitis Media with Otorrhea. Otolaryngology. 133(2). P127–P127. 1 indexed citations
3.
Roland, Peter S., Francis D. Pien, Dan Henry, et al.. (2004). Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/ hydrocortisone for otitis externa. Current Medical Research and Opinion. 20(8). 1175–1183. 24 indexed citations
4.
Roland, Peter S., Debbie Eaton, Robert D. Gross, et al.. (2004). Randomized, Placebo-Controlled Evaluation of Cerumenex and Murine Earwax Removal Products. Archives of Otolaryngology - Head and Neck Surgery. 130(10). 1175–1175. 15 indexed citations
6.
Roland, Peter S., Jack B. Anon, Peter J. Conroy, et al.. (2003). Topical Ciprofloxacin/Dexamethasone is Superior to Ciprofloxacin Alone in Pediatric Patients with Acute Otitis Media and Otorrhea through Tympanostomy Tubes. The Laryngoscope. 113(12). 2116–2122. 56 indexed citations
7.
Rasey, Janet S., Kenneth A. Krohn, Zdenka Grünbaum, et al.. (1985). Further Characterization of 4-Bromomisonidazole as a Potential Detector of Hypoxic Cells. Radiation Research. 102(1). 76–76. 19 indexed citations
8.
Rasey, Janet S., K. A. Krohn, & Peter J. Conroy. (1982). Characterization of 4-bromomisonidazole as a radiosensitizer and a potential detector of hypoxic cells. International Journal of Radiation Oncology*Biology*Physics. 8. 2 indexed citations
9.
Conroy, Peter J., et al.. (1982). Nitroimidazole neurotoxicity: Are mouse studies predictive?. International Journal of Radiation Oncology*Biology*Physics. 8(3-4). 798–803. 11 indexed citations
10.
Sutherland, Robert M., et al.. (1982). In vitro hypoxic cytotoxicity of nitroimidazoles: Uptake and cell cycle phase specificity. International Journal of Radiation Oncology*Biology*Physics. 8(3-4). 745–748. 20 indexed citations
11.
Burg, R. von, David P. Penney, & Peter J. Conroy. (1981). Acrylamide neurotoxicity in the mouse: A behavioral, electrophysiological and morphological study. Journal of Applied Toxicology. 1(4). 227–233. 9 indexed citations
12.
Conroy, Peter J., et al.. (1980). Misonidazole Cytotoxicity in Vivo: A Comparison of Large Single Doses with Smaller Doses and Extended Contact of the Drug with Tumor Cells. Radiation Research. 83(1). 169–169. 8 indexed citations
13.
Conroy, Peter J., et al.. (1980). The effect of misonidazole on some physiologic parameters in mice.. Journal of Pharmacology and Experimental Therapeutics. 212(1). 47–52. 12 indexed citations
14.
Conroy, Peter J., et al.. (1980). Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice. British Journal of Cancer. 41(4). 523–528. 4 indexed citations
15.
Conroy, Peter J.. (1979). Carcinostatic Activity of Methylglyoxal and Related Substances in Tumour‐Bearing Mice. Novartis Foundation symposium. 271–300. 30 indexed citations
16.
Burg, R. von & Peter J. Conroy. (1979). Evaluation of the anticholinesterase activity of metronidazole and misonidazole. European Journal of Pharmacology. 55(4). 417–420. 2 indexed citations
17.
Conroy, Peter J., et al.. (1977). The inhibitory effects of a 4-hydroxy-pentenal: Cysteine adduct against Sarcoma 180 cells in mice. European Journal of Cancer (1965). 13(1). 55–63. 18 indexed citations
18.
Foster, Josh, Peter J. Conroy, A. Searle, & R. L. Willson. (1976). Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells. British Journal of Cancer. 33(5). 485–490. 57 indexed citations
19.
Conroy, Peter J., et al.. (1975). Carcinostatic activity of 4-hydroxy-2-pent-en-1-al against transplantable murine tumour lines. European Journal of Cancer (1965). 11(4). 231–240. 25 indexed citations
20.
Conroy, Peter J.. (1973). Investigation of roof shales in Illinois Coal Mines. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026